See also
ˇ Show More
Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
You have visited 10 password protected pages for free. Others contain data covered by
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Pfizer Inc., Consolidated Statement of Comprehensive Income
USD $ in millions
| 12 months ended | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | Dec 31, 2006 | |
|---|---|---|---|---|---|---|
![]() |
Net income | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Foreign currency translation adjustments | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Reclassification adjustments to income | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Other | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Income taxes | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Currency translation adjustment and other | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Unrealized holding gains (losses) | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Reclassification adjustments to income | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Income taxes | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Derivative financial instruments | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Unrealized holding gains (losses) | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Reclassification adjustments to income | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Income taxes | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Available-for-sale securities | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Net unrealized gains (losses) | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Actuarial gains (losses) and other benefit plan items | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Amortization of actuarial losses and other benefit plan items | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Curtailments and settlements, net | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Other | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Income taxes | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Actuarial gains (losses) | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Actuarial gains (losses) and other benefit plan items | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Amortization of actuarial losses and other benefit plan items | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Curtailments and settlements, net | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Other | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Income taxes | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Prior service (costs) credits and other | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Minimum pension liability adjustment | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Benefit plans | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Other comprehensive income (loss) attributable to noncontrolling interests | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Other comprehensive income (loss) | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Comprehensive income (loss) | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Comprehensive income (loss) attributable to noncontrolling interests | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Comprehensive income (loss) attributable to Pfizer Inc. | ![]() |
![]() |
![]() |
![]() |
![]() |
| Item | Description | The company |
|---|---|---|
| Currency translation adjustment and other | Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity, net of tax, attributable to the parent entity. | Pfizer Inc.'s currency translation adjustment and other increased from 2008 to 2009 but then slightly declined from 2009 to 2010 not reaching 2008 level. |
| Derivative financial instruments | Net of tax effect change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges, after taxes, that is attributable to the parent entity. A cash flow hedge is a hedge of the exposure to variability in the cash flows of a recognized asset or liability or a forecasted transaction that is attributable to a particular risk. The change includes an entity's share of an equity investee's increase (decrease) in deferred hedging gains or losses. | Pfizer Inc.'s derivative financial instruments declined from 2008 to 2009 and from 2009 to 2010. |
| Available-for-sale securities | Gross appreciation or the gross loss in value of the total unsold securities at the end of an accounting period, after tax, attributable to the parent entity. | Pfizer Inc.'s available-for-sale securities increased from 2008 to 2009 but then slightly declined from 2009 to 2010 not reaching 2008 level. |
| Benefit plans | Net changes to accumulated comprehensive income during the period related to benefit plans, after tax, attributable to the parent entity. | Pfizer Inc.'s benefit plans increased from 2008 to 2009 but then slightly declined from 2009 to 2010. |
| Comprehensive income (loss) attributable to Pfizer Inc. | The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent. | Pfizer Inc.'s comprehensive income (loss) attributable to Pfizer Inc. increased from 2008 to 2009 but then slightly declined from 2009 to 2010 not reaching 2008 level. |
February 9, 2012